© All rights reserved to Barnea Jaffa Lande Law offices

Daniel Kleinman
Adv. Daniel Kleinman

Electra City Tower
58 Harakevet St.
Tel Aviv
6777016

Daniel Kleinman

Daniel is a lawyer in the firm’s Commercial Department.

Daniel represents companies, both local and international, in mergers and acquisitions and other commercial transactions. He assists in the preparation of a wide range of commercial agreements, including founders’, shareholders’, investment, service agreements and more.

 

In addition, Daniel provides comprehensive legal counsel to Israeli and foreign corporations on a variety of regulatory matters related to their commercial activities. These include antitrust issues, consumer protection, privacy protection, and more.

 

Daniel also represents non-profit organizations (associations, public benefit companies, etc.), providing them advice on how to obtain the required certifications in order to receive donations according to the tax laws.

 

Daniel completed his internship at Barnea.

Education:


Interdisciplinary Center Herzliya (LL.B., BA in Business Administration) 2015

Admission:


Member of Israel Bar Association since 2016

News and updates - Daniel Kleinman:


June 21, 2022

Amutot and PBCs Set to Independently Update Details and Information

The Israeli website “GuideStar,” which provides information about Amutot (One of the common types of non-profit organizations in Israel) and PBCs, launched a new and important interface that enables these organizations to independently update their details and information.

May 24, 2022

Danel Acquires Additional 10% of Enaim Medical Center

The NIS 43 million acquisition will make Danel the owner of 61% of Enaim Medical Center. Advs. Ilan Blumenfeld and Daniel Kleinman represented Danel in the transaction.

 

March 22, 2022

Representing Danel Group in Completion of Acquisition of Manor Medical

Advs. Micky Barnea, Ilan Blumenfeld, and Daniel Kleinman from our firm represented Danel Group in the acquisition of Manor Medical, which operates in the surrogacy, egg donation, and medical tourism fields. This transaction constitutes the completion of Danel’s acquisition of Manor Medical based on a NIS 100 million valuation.

See all news of Daniel Kleinman >

Enter your email for newsletter sign up: